Calif. Appeals Court Upholds Dismissal of Amiodarone Cases as Preempted, Insufficiently Pled



DOCUMENTS
  • Opinion


SAN FRANCISCO — A California appellate panel has upheld dismissal of actions accusing drug makers of failing to provide a Medication Guide to patients who were prescribed the heart medication amiodarone off-label and were injured as a result, ruling the claims are preempted by federal law.

In a Nov. 3 opinion, the California Court of Appeal, 1st District, further found the Alameda County Superior Court did not err in dismissing claims accusing Wyeth Pharmaceuticals Inc. of unlawfully promoting the drug, affirming they lack the required specificity.

Several hundred individuals filed lawsuits in California superior courts alleging that they suffered serious …






UPCOMING CONFERENCES




HarrisMartin's MDL Conference: Managing Mass Torts, Status of Key Litigations and Lessons Learned

March 29, 2023 - Tucson, AZ
Omni Tucson National Resort

MORE DETAILS



HarrisMartin's New Jersey Asbestos Litigation Conference

March 03, 2023 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS